Danish Designer Creates Wearable Naloxone Injecting Device
This bold new step for harm reduction could make the overdose antidote instantly accessible to people who use opioids.
A Danish urban designer named Morten Groenning is working with the addictions department of Kings College in Denmark to create a wearable device that will make overdose antidote naloxone instantly accessible to people who use opioids. Called INVIO, the device clips on to your arm and, in the event of an overdose, injects naloxone, which can reverse the OD by binding to opioid receptors in the brain.
The gadget is still in the prototype stage, but Groenning has a clear vision of the steps he wants to take so that his product can have a big impact. His goal is for it to cost under $40, and to run primarily on body heat in order to prolong battery life.
Ultimately, Groenning also hopes to create “mini consumption rooms,” located in accessible public places and containing a camera and cheap syringes. Envisioned as green-tinted telephone booth-type spaces, these would allow heroin users to inject in greater safety—another bold step forward on the harm reduction frontier.
In the US, where drug consumption rooms and even federal funding for needle exchange remain illegal, naloxone is increasingly carried by EMTs and law enforcement officers, with lifesaving outcomes. Activists are also campaigning for naloxone to be made available in public areas like malls or movie theaters.
You Might Also Like
New York magazine e-cig polling question New York’s two top magazines, The New Yorker and New York, have blogs today about e-cigs and vaping—a sure sign that electronic... Read More
This time-lapse map shows state-by-state which drugs Americans have searched online over the last decade. ... Read More
Bartenders everywhere should be afraid about the rise of the self-poured beer.... Read More
The "United States of Alcohol" maps America's drinking preferences, from sea to boozy sea.... Read More
Substance.com intercepts another piece of top-level correspondence.... Read More